B

Baird Medical Investment Holdings Ltd
NASDAQ:BDMD

Watchlist Manager
Baird Medical Investment Holdings Ltd
NASDAQ:BDMD
Watchlist
Price: 1.77 USD -1.12% Market Closed
Market Cap: $65m

Baird Medical Investment Holdings Ltd
Long-Term Debt

Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Last Value
3 Years 3Y CAGR
5 Years 5Y CAGR
10 Years 10Y CAGR
Quarterly
Annual
|
See Also

Baird Medical Investment Holdings Ltd
Long-Term Debt Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Long-Term Debt CAGR 3Y CAGR 5Y CAGR 10Y
B
Baird Medical Investment Holdings Ltd
NASDAQ:BDMD
Long-Term Debt
$3.4m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Modern Dental Group Ltd
HKEX:3600
Long-Term Debt
HK$655.2m
CAGR 3-Years
0%
CAGR 5-Years
-4%
CAGR 10-Years
2%
Vincent Medical Holdings Ltd
HKEX:1612
Long-Term Debt
HK$137.6m
CAGR 3-Years
200%
CAGR 5-Years
159%
CAGR 10-Years
N/A
No Stocks Found

Baird Medical Investment Holdings Ltd
Glance View

Market Cap
65m USD
Industry
Health Care

Baird Medical Investment Holdings Ltd is a HK-based company operating in Health Care Equipment & Supplies industry. Baird Medical Investment Holdings Ltd is a company mainly engaged in the microwave ablation medical device business. The firm is mainly engaged in the provision of microwave ablation medical device. The medical devices are used for treatment of benign and malignant tumors, including thyroid nodules, liver cancer, lung cancer and breast lumps.

BDMD Intrinsic Value
LOCKED
Unlock

See Also

What is Baird Medical Investment Holdings Ltd's Long-Term Debt?
Long-Term Debt
3.4m USD

Based on the financial report for Dec 31, 2024, Baird Medical Investment Holdings Ltd's Long-Term Debt amounts to 3.4m USD.

What is Baird Medical Investment Holdings Ltd's Long-Term Debt growth rate?
Long-Term Debt CAGR 1Y
113%

Over the last year, the Long-Term Debt growth was 113%.

Back to Top
Get AI-powered insights for any company or topic.
Open AI Assistant

Intrinsic Value is all-important and is the only logical way to evaluate the relative attractiveness of investments and businesses.

Warren Buffett